THE TREATMENT OF IDIOPATHIC ORTHOSTATIC HYPOTENSION - A COMBINED FLUDROCORTISONE AND FLURBIPROFEN REGIME

Authors:
  • SWSJ WATT
    SJ WATT
  • JTJE TOOKE
    JE TOOKE
  • CPCM PERKINS
    CM PERKINS
  • MLMR LEE
    MR LEE

  • 1 January 1981
    • journal article
    • research article
    • Vol. 50  (198) , 205-212
    • PMID:7302119
Abstract
The management is reported of idiopathic orthostatic hypotension using the prostaglandin synthetase inhibitor, flurbiprofen. In 5 subjects with proven autonomic failure the effect on blood pressure of the addition of flurbiprofen (or fludrocortisone) to the previous drug regime was assessed. Both lying and standing blood pressure were seen to rise with fludrocortisone treatment but the change in standing blood pressure was not statistically significant. Flurbiprofen produced no change in lying blood pressure but a significant rise in standing blood pressure. Digital blood flow measurements were made on 3 subjects before and after flurbiprofen and a dose-related reduction in post-occlusive reactive hyperemia the drug may affect precapillary smooth muscle tone. Two patients failed to maintain a long-term response to treatment with flurbiprofen and fludrocortisone but were helped by the addition of ephedrine or tyramine and a monoamine oxidase inhibitor (phenelzine). A stepwise approach to treatment is recommended in this condition commencing with flurbiprofen and adding fludrocortisone later if necessary. This approach may offer the maximum benefit with a minimum of side effects.